Prenatal blockade of vasoactive intestinal peptide alters cell death and synaptic equipment in the murine neocortex

Pediatric Research

Volumn 47, Issue 1, 2000, Pages 53-63

  Zupan, Véronique ^a,c   Nehlig, Astrid ^b   Evrard, Philippe ^a   Gressens, Pierre ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b INSERM   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; GROWTH FACTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; BRAIN DEVELOPMENT; CELL DEATH; CELL SURVIVAL; COGNITIVE DEFECT; CONTROLLED STUDY; MOUSE; NEOCORTEX; NICK END LABELING; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

EID: 0033982587     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200001000-00012     Document Type: Article

References (53)

1. Paneth N, Rudelli R, Kazan E, Monte W 1994 Brain Damage in the Preterm Infant. Mac Keith Press, London, pp 99-137
2. Crawford CL, Hobbs MJ 1994 Anatomy of diplegia: an hypothesis. Dev Med Child Neurol 36:513-517
3. Luoma L, Herrgard E, Martikainen A 1998 Neuropsychological analysis of the visuomotor problems in children born preterm at <32 wk of gestation: a 5-year prospective follow-up. Dev Med Child Neurol 40:21-30
4. Evrard P, Gressens P, Volpe JJ 1992 Neurological consequences of subcortical lesions in the premature brain: new concepts based upon developmental biology. Biol Neonate 61:1-3
5. Marin-Padilla M 1997 Developmental neuropathology and impact of perinatal brain damage: II. White matter lesions of the neocortex. J Neuropathol Exp Neurol 56:219-235
6. Antonini A, Schatz CJ 1990 Relation between putative transmitter phenotypes and connectivity of subplate neurons during cerebral cortical development. Eur J Neurosci 2:744-761
7. Kostovic I, Rakic P 1990 Developmental history of the transient subplate zone in the visual and somatosensory cortex of the macaque monkey and human brain. J Comp Neurol 297:441-470
8. Volpe JJ 1995 Neurology of the Newborn. WB Saunders, Philadelphia, pp 279-313
9. Gressens P, Richelme C, Kadhim HJ, Gadisseux JF, Evrard P 1992 The germinative zone produces most cortical astrocytes after neuritic migration in developing mammalian brain. Biol Neonate 61:4-24
10. Kadhim HJ, Gadisseux JF, Evrard P 1989 Topographical and cytological evolution of the glial phase during prenatal development of the human brain: histochemical and electron microscopic study. J Neuropathol Exp Neurol 47:166-188
11. Jammes JL, Gilles FH 1983 Telencephalic development: matrix volume and isocortex and allocortex surface areas. In: Gilles FH, Leviton A, Dooling EC (eds) The Developing Human Brain: Growth and Epidemiologic Neuropathology. J Wright PSG, Boston, pp 87-93
12. Delanay CL, Brenner M, Messing A 1996 Conditional ablation of astrocytes in postnatal transgenic mice. J Neurosci 16:6908-6918
13. Loughlin SE, Fallon JH 1993 Neurotrophic Factors. Academic Press, San Diego, pp 1-24
14. Unterman TG, Buchanan TA, Freinkel N 1989 Access to maternal insulin to the rat conceptus prior to allantoic placentation. Diabetes Res 10:115-120
15. Obregon MJ, Mallol J, Pastor R, Morreale de Escobar G 1984 L-Thyroxine and 3,3′,5′-triiodo-L-thyroxine in rat embryos before onset of fetal thyroid function. Endocrinology 114:305-307
16. Medlock ES, Kaplan DL, Cecchini M, Ulich TR, del Castillo J, Andresen J 1993 Granulocyte-macrophage colony-stimulating factor crosses the placenta and stimulates fetal rat granulopoiesis. Blood 81:916-922
17. Letterio JJ, Geiser AG, Kulkami AB, Roche NS, Sporn MB, Roberts AB 1994 Maternal rescue of transforming growth factor-beta1 null mice. Science 264:1936-1938
18. Hill JM, McCune SK, Alvero RJ, Glazner GW, Henins KA, Stanziale SF, Keimowitz JR, Brenneman DE 1996 Maternal vasoactive intestinal peptide and the regulation of embryonic growth in rodents. J Clin Invest 97:202-208
19. Ottesen B, Ulrichsen H, Fahrenkrug J, Larsen JJ, Wagner G, Schierup L, Sondergaard F 1982 Vasoactive intestinal polypeptide and the female genital tract: relationship to reproductive phase and delivery. Am J Obstet Gynecol 143:414-420
20. 2 receptor in mouse neocortical astrocytogenesis. J Neurochem 70:2165-2173
21. Gozes I, Meltzer E, Rubinraut S, Brenneman DE 1989 Vasoactive intestinal peptide potentiates sexual behavior: inhibition by a novel antagonist. Endocrinology 125:2945-2949
22. Gozes I, McCune SK, Jacobson L, Warren D, Moody TW, Fridkin M, Brenneman DE 1991 An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system. J Pharmacol Exp Ther 257:959-966
23. Gozes Y, Brenneman DE, Fridkin M, Asofsky R, Gozes I 1991 A VIP antagonist distinguishes VIP receptors in spinal cord and lymphocytes. Brain Res 540:319-321
24. Gressens P, Hill JM, Paindaveine B, Gozes I, Fridkin M, Brenneman DE 1994 Blockade of vasoactive intestinal peptide function in early mouse embryo induces a severe microcephaly. J Clin Invest 94:2020-2027
25. Hill JM, Agoston DV, Gressens P, McCune SK 1994 Patterns of distribution of VIP mRNA and two distinct VIP receptors in the developing rat brain: relation to ontogenic events. J Comp Neurol 342:186-205
26. Hill JM., Gozes I, Hill JL, Fridkin M, Brenneman DE 1991 Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the rat. Peptides 12:187-192
27. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28:897-916
28. Nehlig A, Pereira de Vasconcelos A, Boyet S 1988 Quantitative autoradiographic measurement of local cerebral glucose utilization in freely moving rats during postnatal development. J Neurosci 8:2321-2333
29. Jay TM, Jouvet M, DesRosiers MH 1985 Local cerebral glucose utilisation in the free moving mouse: a comparison during two stages of the activity-rest cycle. Brain Res 342:297-306
30. 14C]-glucose method to the mouse for measuring local cerebral glucose utilisation. Eur Neurol 20:169-172
31. Lamboley G, Evrard P, Gressens P 1999 Inhibition prénatale du peptide vasoactif intestinal el lésions cérébrales excitotoxiques du souriceau nouveau-né. Arch Pediatr 6:67-74
32. Festoff BE, Nelson PG, Brenneman DE 1996 Prevention of activity-dependent neuritic death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting, neurotrophic serpin, protease nexin I. J Neurobiol 30:255-266
33. Brenneman DE, Gozes I 1996 A femtomolar-acting neuroprotective peptide. J Clin Invest 97:2299-2307
34. Pellegri G, Magistretti PJ, Martin JL 1998 VIP and PACAP potentiate the action of glutamate on BDNF expression in cortical neurones. Eur J Neurosci 10:272-280
35. Brenneman DE, Hill JM, Glazner GW, Gozes I, Phillips TM 1995 Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuritic survival. Int J Dev Neurosci 13:187-200
36. Hill JM, Agoston DV, Gressens P, McCune SK 1994 Distribution of VIP mRNA and two distinct VIP binding sites in the developing rat brain: relation to ontogenic events. J Comp Neurol 342:186-205
37. Voyvodic JT 1996 Cell death in cortical development: how much? Why? So what? Neuron 16:693-696
38. Gressens P, Muaku S, Besse L, Nsegbe E, Gallego J, Delpech B, Gaultier C, Evrard P, Ketelslegers P, Maiter D 1997 Maternal protein restriction early in rat pregnancy alters brain development in the progeny. Dev Brain Res 103:21-35
39. Bartolomei JC, Greer CA 1998 The organization of piriform cortex and the lateral olfactory tract following the loss of mitral cells in PCD mice. Exp Neurol 154:537-550
40. Sasaki S, Iwata M 1996 Dendritic synapses of anterior horn neurons in amyotrophic lateral sclerosis: an ultrastructural study. Acta Neuropathol 91:278-283
41. Represa A, Niquet J, Pollard H, ben-Ari Y 1995 Cell death, gliosis and synaptic remodeling in the hippocampus of epileptic rats. J Neurobiol 26:413-425
42. Van Ooyen A, Van Pelt J, Corner MA 1995 Implications of activity dependent neurite outgrowth for neuritic morphology and network development. J Theor Biol 172:63-82
43. Pincus DW, DiCicco-Bloom EM, Black IB 1990 Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature 343:564-567
44. Pence JC, Shorter NA 1990 In vitro differentiation of human neuroblastoma cells caused by vasoactive intestinal peptide. Cancer Res 50:5177-5183
45. Magistretti PJ, Pellerin L, Martin JL 1995 Brain energy metabolism: an integrated cellular perspective. In: Bloom FE (ed) Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, pp 657-670
46. Petralia RS, Esteban JA, Wang YX, Partridge JG, Zhao HM, Wenthold RJ, Malinow R 1999 Selective acquisition of AMAP receptors over postnatal development suggests a molecular basis for silent synapses. Nature Neurosci 2:31-36
47. Arimura A 1992 Receptors for pituitary adenylate cyclase-activating polypeptide: comparison with vasoactive intestinal peptide receptors. Trends Endocrinol Metab 3:288-294
48. Gressens P, Marret S, Hill JM, Brenneman DE, Gozes I, Fridkin I, Evrard P 1997 Vasoactive intestinal peptide prevents excitotoxic hypoxic-like cell death in the murine developing brain. J Clin Invest 100:390-397
49. Gressens P, Paindaveine B, Hill JM, Evrard P, Brenneman DE 1998 Vasoactive intestinal peptide shortens both G1 and S phases of cell cycle in whole cultured mouse embryos. Eur J Neurosci 10:1734-1742
50. Ottesen B, Ulrichsen H, Fahrenkrug J, Larsen JJ, Wagner L, Schierup L, Sondergaard F 1982 Vasoactive intestinal polypeptide and the female genital tract: relationship to reproductive phase and delivery. Am J Obstet Gynecol 143:414-420
51. Hayashi M 1991 Ontogeny of some neuropeptides in the primate brain. Prog Neurobiol 38:231-260
52. Waschek JA, Ellison J, Bravo DT, Handley V 1996 Embryonic expression of vasoactive intestinal peptide (VIP) and VIP receptor genes. J Neurochem 66:1762-1765
53. Tatsuno I, Somogyvari-Vigh A, Arimura A 1994 Developmental changes of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor in the rat brain. Peptides 15:55-60